Tiverton Asset Management’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-14,494
Closed -$360K 542
2018
Q1
$360K Sell
14,494
-42,984
-75% -$1.05M 0.03% 251
2017
Q4
$1.39M Sell
57,478
-40,926
-42% -$1.08M 0.09% 170
2017
Q3
$2.72M Sell
98,404
-12,338
-11% -$329K 0.15% 133
2017
Q2
$2.78M Sell
110,742
-36,914
-25% -$914K 0.15% 139
2017
Q1
$3.96M Hold
147,656
0.2% 134
2016
Q4
$3.87M Hold
147,656
0.23% 119
2016
Q3
$3.69M Sell
147,656
-37,999
-20% -$886K 0.3% 104
2016
Q2
$2.95M Sell
185,655
-130,099
-41% -$2.32M 0.12% 123
2016
Q1
$4.73M Sell
315,754
-159,246
-34% -$2.67M 0.16% 113
2015
Q4
$10.4M Sell
475,000
-225,000
-32% -$4.19M 0.33% 91
2015
Q3
$11M Hold
700,000
0.24% 92
2015
Q2
$10M Hold
700,000
0.2% 115
2015
Q1
$12.1M Hold
700,000
0.25% 94
2014
Q4
$12.6M Hold
700,000
0.26% 92
2014
Q3
$9.19M Hold
700,000
0.21% 96
2014
Q2
$10.1M Hold
700,000
0.23% 96
2014
Q1
$8.92M Hold
700,000
0.19% 105
2013
Q4
$7M Hold
700,000
0.15% 105
2013
Q3
$9.21M Hold
700,000
0.22% 95
2013
Q2
$10M Buy
+700,000
New +$8.8M 0.26% 86

Other funds holding NXTM

Tiverton Asset Management's NXTM Position: Q2 2018 in Review

Tiverton Asset Management sold out of NxStage Medical Inc. (NXTM) in Q2 2018, closing a stake of 14,494 shares — an estimated $360K sold.

Tiverton Asset Management first reported a position in NXTM in Q2 2013 and held it in 20 quarters. The position peaked at $12.6M in Q4 2014. 171 funds tracked by Wall St. Rank hold NXTM as of Q2 2018.

  • Tiverton Asset Management reported no remaining NxStage Medical Inc. position as of Q2 2018 after selling out during the quarter.
  • Tiverton Asset Management sold 14,494 NxStage Medical Inc. shares in Q2 2018, an estimated $360K.
  • Tiverton Asset Management first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 20 quarters.
  • Tiverton Asset Management's NxStage Medical Inc. position peaked at $12.6M in Q4 2014.
  • 171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2018.

Based on Tiverton Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.